Combined metabolic activators to treat mitochondrial dysfunction Mitochondrial dysfunction is a common feature of many human diseases and is emerging as a therapeutic target. Systems biology and multiomics approaches have revealed that The Importance of the Fatty Acid Transporter L Carnitine in Non Alcoholic Fatty Liver Disease (NAFLD) How is NAD+ Made? De Novo Synthesis Qualia Schematic illustration of L carnitine synthesis from the precursor TML. Download Scientific Diagram